Literature DB >> 9790109

Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology.

W Kempf1, A C Haeffner, B Mueller, R G Panizzon, G Burg.   

Abstract

The diagnosis of lymphoproliferative and melanocytic skin lesions is one of the most vexing problems in dermatopathology, a problem that is compounded by the far-reaching therapeutic and psychosocial consequences of the diagnosis for both patient and physician. On the occasion of a self-assessment slide seminar held during a dermatopathology meeting, 30 unusual lymphoproliferative and melanocytic lesions, each provided with four differential diagnoses, were evaluated by "expert pathologists" and other participants ("nonexperts") of the slide seminar. The final diagnosis was pinpointed by the majority of the experts in 16 of 30 cases (56%). The group of experts returned an unanimous decision on the diagnosis in only 2 of the 30 cases (7%). In contrast to the expert group, the preferred diagnoses given by the nonexperts showed a wider range. In 20 of 30 cases (66%), the final diagnosis could only be established after consideration of clinical, histologic, immunophenotypic, and molecular features. Our findings agree with the results of recent studies indicating quite a high degree of discordance among expert pathologists. The discordance between experts and, to a higher extent, nonexperts may have some crucial consequences for dermatopathology. Full agreement on diagnosis, particularly in unusual skin lesions, cannot be achieved only by an accumulation of expertises. Instead of relying on one single finding or diagnostic procedure ("gold standard") as the main criterion upon which to base a diagnosis, the diagnoses become more reliable if based on the integration of several factors including an evaluation of clinical and histomorphologic features and immunophenotypic and molecular findings ("diagnostic elements"), particularly in the field of lymphoproliferative and melanocytic lesions. In addition, a continuous retrospective work-up of difficult or unusual cases is recommended to ensure a long-term improvement in diagnostic reliability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790109     DOI: 10.1097/00000372-199810000-00009

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  5 in total

1.  High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.

Authors:  Szu-Ying Chin; Pei-Ru Wu; Yi-Hsien Shih; Chung-Min Yeh; Woan-Ruoh Lee; Shing-Chuan Shen; Kun-Tu Yeh; Ming-Chung Jiang; Jonathan Te-Peng Tseng
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma.

Authors:  Jeffrey P North; John T Vetto; Rajmohan Murali; Kevin P White; Clifton R White; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

Review 3.  Problematic pigmented lesions: approach to diagnosis.

Authors:  S L Edwards; K Blessing
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

4.  [DNA copy number changes in the diagnosis of melanocytic tumors].

Authors:  J Bauer; B C Bastian
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

5.  Fluorescence in situ hybridization testing of chromosomes 6, 8, 9 and 11 in melanocytic tumors is difficult to automate and reveals tumor heterogeneity in melanomas.

Authors:  Arnaud Uguen; Marie Uguen; Matthieu Talagas; Eric Gobin; Pascale Marcorelles; Marc De Braekeleer
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.